Clinical Trials Browser

Completed × Ovarian Neoplasms × Monitoring, Physiologic × Clear all

NCT03685695 2021-09-02

Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms